510(k) · Cleared
ClearedModification to Proxis System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
St Jude Medical · NFA Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection
Cleared on Jan 31, 2008 as substantially equivalent to K060651 (St Jude Medical, 2006) and 1 other predicate after a 43-day review. Its family tree reaches back 5 generations to 2001.
- Decided
- Jan 31, 2008
- Review
- 43 days
- Class
- Class II
- Product code
- NFA
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 5 generations to K010579 (2001). 22 ancestors in all, the oldest K913517 (1991). No later device cites it as a predicate yet.
- Root · 5 generations backK010579 Stent Support Guide CatheterMedtronic Vascular · 2001 · Recalled
- 4 generations backK030201 Modification to Export Aspiration CatheterMedtronic Vascular · 2003
- 3 generations backK040869 Export CatheterMedtronic Vascular · 2004
- 2 generations backK050139 Modification to: Export CatheterMedtronic Vascular · 2005
- 1 generation backK052523 Proxis SystemVelocimed, Inc. · 2006
- This deviceK073563 Modification to Proxis SystemSt Jude Medical · 2008
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K010579 | Stent Support Guide Catheter | Medtronic Vascular | 2001 | 27 |
| −4 | K030201 | Modification to Export Aspiration Catheter | Medtronic Vascular | 2003 | — |
| −3 | K040869 | Export Catheter | Medtronic Vascular | 2004 | — |
| −2 | K050139 | Modification to: Export Catheter | Medtronic Vascular | 2005 | — |
| −1 | K052523 | Proxis System | Velocimed, Inc. | 2006 | — |
| 0 (this device) | K073563 | Modification to Proxis System | St Jude Medical | 2008 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1993 | 1 | 0 |
| 1995 | 1 | 0 |
| 1999 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 0 |
| 2003 | 4 | 0 |
| 2005 | 3 | 0 |
| 2006 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NFA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K060651 | Proxis System, Model EPS101Summary page 3…ion, control of flow of fluids, and aid in the removal of fresh soft thrombi and emboli. The modified Proxis System is physically identical to the cleared Proxis System (K060651, Sept. 13, 2006)), with the exception of a non-significant change in material for the occluding balloon. In addition, a precautio… | 2006 |
| * | K052523 | Proxis SystemSummary page 2…s from the treatment site. 5.4 Intended Use There is no change to the intended use of the modified Proxis System as it is identical to the predicate Proxis System, K052523-Sept. 7, 2006. The Proxis System is indicated for use as a proximal embolic protection system to prevent distal release of and… | 2006 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 1.3 years on median.
- 3 of the 22 ancestors have a recall of any class.
- 1 other device also cites its predicate K060651.
How does its category compare?
All NFA devicesNFA Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.
FDA decisions per year · NFA
2in 2008
2026 to Oct 25, outlined.
Median 510(k) review, days · NFA
Too few NFA 510(k)s in any year since 2007 to give a median.
Recalls per year · NFA
No recall names NFA since 2007.
Adverse event reports per year · NFA
91in 2025
MAUDE reports naming product code NFA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 110 |
| 2008 | 2 | — | 0 | 80 |
| 2009 | 0 | — | 0 | 104 |
| 2010 | 0 | — | 0 | 183 |
| 2011 | 0 | — | 0 | 45 |
| 2012 | 0 | — | 0 | 55 |
| 2013 | 0 | — | 0 | 48 |
| 2014 | 0 | — | 0 | 42 |
| 2015 | 0 | — | 0 | 41 |
| 2016 | 0 | — | 0 | 63 |
| 2017 | 0 | — | 0 | 50 |
| 2018 | 0 | — | 0 | 78 |
| 2019 | 0 | — | 0 | 40 |
| 2020 | 0 | — | 0 | 20 |
| 2021 | 0 | — | 0 | 25 |
| 2022 | 0 | — | 0 | 23 |
| 2023 | 0 | — | 0 | 22 |
| 2024 | 0 | — | 0 | 55 |
| 2025 | 0 | — | 0 | 91 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Proxis System is indicated for use as a proximal embolic protection system to prevent distal release of and to aspirate embolic material (thrombus/debris) in saphenous vein coronary bypass graft(s) (3.0 mm - 5.0 mm) during percutaneous transluminal coronary angioplasty and/or stenting procedures. The Proxis System is also indicated to control the flow of fluids and aid in the removal of fresh, soft emboli and thrombi in the coronary and peripheral…
Read the full statement (119 words)
The Proxis System is indicated for use as a proximal embolic protection system to prevent distal release of and to aspirate embolic material (thrombus/debris) in saphenous vein coronary bypass graft(s) (3.0 mm - 5.0 mm) during percutaneous transluminal coronary angioplasty and/or stenting procedures.
The Proxis System is also indicated to control the flow of fluids and aid in the removal of fresh, soft emboli and thrombi in the coronary and peripheral vasculature.
The safety and effectiveness of this device as an embolic protection system has not been established in the cerebral, carotid or peripheral vasculature; native coronary arteries; or for treatment of patients with acute myocardial infarction. The device is not intended to be used as a thrombectomy system.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K073563 · printed Nov 6, 2026
Cite this page
510(k) Report. “K073563: Modification to Proxis System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K073563
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026